Floatz logo

DROPERIDOL

Gallstones

Zhejiang UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Gallstones cohort.

Asset / SponsorPhaseRating
URSODEOXYCHOLIC ACID
Sahlgrenska University Hospital
Phase 2B
Obeticholic Acid
Sahlgrenska University Hospital
Phase 2CCC
Arachidyl amido cholanoic acid
Galmed Pharmaceuticals Ltd
Phase 2CCC
Palonosetron
Zhejiang University
N/AD
DEXAMETHASONE
Zhejiang University
N/AD

Same molecule, other indications

DROPERIDOL is also rated in:

Postoperative Pain, AcuteDormant
BB
Indicative ·
65 / 100
View asset →
Postoperative Pain, ChronicDormant
BB
Indicative ·
65 / 100
View asset →
Systemic Inflammatory Response SyndromeDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →